ASCT offers member discounts on live and recorded archived digital presentations.
You will receive your real-time presentation access link via email from ASCT after payment is processed. Participants can choose to hear the audio via the phone or over their computer speakers. Each presentation will offer one CE credit as defined by the ASCP CMP. Archived presentations available for one year from date of purchase. CE available for one year only from date of original purchase for original registrants only.
All Members and Non-Members may purchase ASCT educational webinars online by clicking here.
$50 member (price per webinar)
$65 non-member (price per webinar)
2023 Webinar Registration Form
$250 member registers lab (price per webinar)
$300 non-member registers lab (price per webinar)
$1000 Member signs up the lab (all webinars in current year) limited to 10 lab registrants
(complete to register)
February 20, 2023 | 2:00pm EST
Live Presentation: Pancreas Cytology: "Learning from difficult cases and turning your pain into gain. A case-based presentation."
view recorded version here
Maria Policarpio-Nicolas, MD
1. Identify the cytologic features of benign/reactive and inflammatory entities that could potentially mimic pancreatic neoplasms/malignancies.
2. Recognize the cytologic variants of pancreatic neoplasms/malignancies which could mimic benign/inflammatory entities.
3. Understand the usefulness as well as limitation of ancillary studies in the differential diagnosis of pancreatic neoplasms/malignancies from benign/inflammatory entities.
March 30, 2023 | 2:00pm EST
A journey Through the Paris System, and Where to Next?
View recorded version here
Dr. Christopher VandenBussche
Associate Professor of Pathology and Oncology
Johns Hopkins University School of Medicine
1. List the diagnostic categories of The Paris System and the cytomorphologic criteria associated with each category.
2. Explain how low grade urothelial neoplasms should be classified according to The Paris System.
3. Describe some unusual morphologies of high grade urothelial carcinoma in urinary tract specimens.